Daniel Miller, MD
Vascular Neurology · Detroit, MINPI 1427269232
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,199 of the $5,397 with a category attached, or 96.3%. 4 manufacturers reported payments, led by Braemar Manufacturing, LLC at 50.4% of the total. Reporting peaked in 2019 at $2,857 and has fallen 98.6% since, to $40 in 2021.
Across 7 payments — averaging $770.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braemar Manufacturing, LLC$3K
- Boston Scientific$3K
- Amgen$22
- Medtronic$18
Across 73 payments — averaging $2744.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$177K
- Genentech, Inc.$14K
- Daiichi Sankyo Inc.$7K
- W. L. Gore & Associates, Inc.$2K
What the payments were for
- Speaking & faculty fees$5,19996%
- Food & beverage$1974%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braemar Manufacturing, LLC | 2 | $2,717 |
| Boston Scientific | 3 | $2,640 |
| Amgen | 1 | $22 |
| Medtronic | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cardiac Monitoring Suite$2,699
- Watchman$2,500
How this compares
$5,397 in reported general payments places this provider in the 75th percentile of 29 vascular neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 57 | $63,914 |
| EliquisApixaban | 27 | $32,981 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $19,494 |
| Lacosamide | 19 | $4,945 |
| Levetiracetam | 96 | $3,204 |
| Atorvastatin Calcium | 172 | $2,210 |
| ClopidogrelClopidogrel Bisulfate | 124 | $1,878 |
| Pregabalin | 40 | $1,237 |
| Cilostazol | 42 | $1,167 |
| Gabapentin | 53 | $881 |
| Memantine Hcl | 15 | $736 |
| Losartan Potassium | 48 | $712 |
| Memantine Hcl ErMemantine Hcl | 13 | $684 |
| AmantadineAmantadine Hcl | 15 | $532 |
| Lamotrigine | 15 | $359 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Detroit
- Mounzer Yassin KassabEast Lansing$443K
- Aniel MajjhooFlint$432K
- David RosenbaumTraverse City$121K
- Anmar RazakEast Lansing$86K
- Surindar JollyWayne$25K
- Fazeel SiddiquiWyoming$14K
- Dawn KleindorferAnn Arbor$7K
- Jiangyong MinGrand Rapids$4K
- George DillonClinton Township$4K
- Devin SimonLansing$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.